HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Temjenmongla Imchen Selected Research

Aberrant Crypt Foci

9/2013Characterization of PPAR dual ligand MCC-555 in AOM-induced colorectal tumorigenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Temjenmongla Imchen Research Topics

Disease

2Neoplasms (Cancer)
09/2013 - 09/2012
2Carcinogenesis
09/2013 - 09/2012
1Hyperlipidemias (Hyperlipidemia)
09/2013
1Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2013
1Hyperglycemia
09/2013
1Aberrant Crypt Foci
09/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
09/2012

Drug/Important Bio-Agent (IBA)

2netoglitazoneIBA
09/2013 - 09/2012
2LigandsIBA
09/2013 - 09/2012
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
09/2013 - 09/2012
1AzoxymethaneIBA
09/2013
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2012
1PPAR gammaIBA
09/2012
1Proteins (Proteins, Gene)FDA Link
09/2012

Therapy/Procedure

1Chemoprevention
09/2012